Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
BMC Medical Research Methodology
|
July 19, 2020
WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
Xuan Zhang, Liang Lan, Jacky C P Chan, et al.
The American Journal of Chinese Medicine
|
September 10, 2020
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)
Xuan Zhang, Ran Tan, Wai Ching Lam, et al.
Chinese Journal of Integrative Medicine
|
August 16, 2018
Whether Syndrome Differentiation Affects Treatment Result: Study Protocol of MaZiRenWan () for Functional Constipation in A Randomized Controlled Trial
Chung-Wah Cheng, Li Zhang, Chen Zhao, et al.
Frontiers in Pharmacology
|
March 11, 2024
Evaluation of compliance of CONSORT-CHM formula 2017 in randomized controlled trials of Chinese herbal medicine formulas: protocol of a five-year review
Juan Wang, Chung Wah Cheng, Yalin Jiao, et al.
Systematic Reviews
|
October 26, 2020
PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
Xuan Zhang, Ran Tan, Wai Ching Lam, et al.
Frontiers of Medicine
|
August 8, 2024
Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
Xuan Zhang, Han Li, Hanzhi Tan, et al.
Journal of Integrative Medicine
|
March 8, 2013
Extending the CONSORT Statement to moxibustion
Chung-wah Cheng, Shu-fei Fu, Qing-hui Zhou, et al.
Chinese Medicine
|
March 3, 2022
A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients
Chung-Wah Cheng, Hoi-Fung Mok, Cora W S Yau, et al.
Chinese Medicine
|
November 14, 2021
Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
Ya Zheng, Jessica Ching, Chung Wah Cheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 15, 2018
Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled Trial
Linda L D Zhong, Chung-Wah Cheng, Wai Kun, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
BMC Medical Research Methodology
|
July 19, 2020
WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration
Xuan Zhang, Liang Lan, Jacky C P Chan, et al.
The American Journal of Chinese Medicine
|
September 10, 2020
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)
Xuan Zhang, Ran Tan, Wai Ching Lam, et al.
Chinese Journal of Integrative Medicine
|
August 16, 2018
Whether Syndrome Differentiation Affects Treatment Result: Study Protocol of MaZiRenWan () for Functional Constipation in A Randomized Controlled Trial
Chung-Wah Cheng, Li Zhang, Chen Zhao, et al.
Frontiers in Pharmacology
|
March 11, 2024
Evaluation of compliance of CONSORT-CHM formula 2017 in randomized controlled trials of Chinese herbal medicine formulas: protocol of a five-year review
Juan Wang, Chung Wah Cheng, Yalin Jiao, et al.
Systematic Reviews
|
October 26, 2020
PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
Xuan Zhang, Ran Tan, Wai Ching Lam, et al.
Frontiers of Medicine
|
August 8, 2024
Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
Xuan Zhang, Han Li, Hanzhi Tan, et al.
Journal of Integrative Medicine
|
March 8, 2013
Extending the CONSORT Statement to moxibustion
Chung-wah Cheng, Shu-fei Fu, Qing-hui Zhou, et al.
Chinese Medicine
|
March 3, 2022
A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients
Chung-Wah Cheng, Hoi-Fung Mok, Cora W S Yau, et al.
Chinese Medicine
|
November 14, 2021
Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
Ya Zheng, Jessica Ching, Chung Wah Cheng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 15, 2018
Efficacy of MaZiRenWan, a Chinese Herbal Medicine, in Patients With Functional Constipation in a Randomized Controlled Trial
Linda L D Zhong, Chung-Wah Cheng, Wai Kun, et al.
Page
of 4